Impact of height and weight on acenocoumarol and phenprocoumon dose needed

Impact of height and weight on acenocoumarol and phenprocoumon dose needed - pre-EU-PACT study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32954

Enrollment

2000

Registered

2009-08-24

Start date

2009-11-10

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fribrillation Thrombosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: INR target between 2.5 and 3.5 18 years or older no participation at vitamin K study (VIKS2A)

Exclusion criteria

Exclusion criteria: Pregnancy or lactation Severe cognitive impairment

Design outcomes

Primary

Measure	Time frame
The impact of height and weight on the coumarin dose required. This will be investigated with lineair regression.	—

Secondary

Measure	Time frame
The dataset will be used as validation of the already developed acenocoumarol and phenrocoumon dosing algorithms.	—

Countries

Netherlands

Outcome results